TABLE 2.
Characterizations of vancomycin-resistant enterococcia
| Species | Strain no. | Patientb | Antimicrobial drug resistance level (MIC, μg/ml)c
|
Drug resistance pattern | Vanr plasmid type harbored in strain | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apc | Erm | Gen | Kan | Str | Tet | Tei | Van | |||||
| E. faecium | FH1 | A | 256 | >128 | 2 | >1,024 | 1,024 | >256 | 32 | 256 | Apc Erm Kan Str Tet Tei Van | α |
| E. faecium | FH2 | B | 256 | >128 | 2 | >1,024 | 512 | >256 | 64 | 256 | Apc Erm Kan Str Tet Tei Van | β |
| E. faecium | FH3 | C | 2 | 4 | 2 | 64 | 64 | 1 | 64 | 512 | Tei Van | β |
| E. faecium | FH4 | D | 128 | >128 | 2 | >1,024 | 256 | >256 | 64 | 256 | Apc Erm Kan Tet Tei Van | β |
| E. faecium | FH5 | E | 64 | >128 | 1 | >1,024 | 1,024 | >256 | 128 | 512 | Apc Erm Kan Str Tet Tei Van | β |
| E. faecium | FH6 | F | 64 | >128 | 2 | >1,024 | 1,024 | >256 | 64 | 256 | Apc Erm Kan Str Tet Tei Van | β |
| E. faecium | FH7 | G | 128 | >128 | >256 | >1,024 | 1,024 | 32 | 128 | 512 | Apc Erm Gen Kan Str Tet Tei Van | γ |
| E. faecium | FH8 | H | 128 | >128 | >256 | >1,024 | >1,024 | 2 | 128 | 512 | Apc Erm Gen Kan Str Tei Van | γ |
| E. faecium | FH9 | I | 128 | >128 | >256 | >1,024 | >1,024 | 128 | 128 | 512 | Apc Erm Gen Kan Str Tet Tei Van | γ |
| E. faecium | FH10 | J | 128 | >128 | >256 | >1,024 | >1,024 | 128 | 128 | >1,024 | Apc Erm Gen Kan Str Tet Tei Van | γ |
| E. avium | FH11 | C | 16 | 0.25 | 2 | 128 | 64 | 16 | 16 | 256 | Apc Tet Tei Van | β |
| E. avium | FH12 | E | 16 | 0.25 | 1 | 64 | 64 | 256 | 16 | 512 | Apc Tet Tei Van | β |
The isolation of VanA-type VRE from clinical sources is still rare in Japan (i.e., fewer than 30 cases) (16, 33; N. Fujita, M. Yoshimura, T. Komori, K. Tanimoto, and Y. Ike, Letter, Antimicrob. Agents Chemother. 42 :2150, 1998; Y. Ike, K. Tanimoto, Y. Ozawa, T. Nomura, S. Fujimoto, and H. Tomita, Letter, Lancet 353:1854, 1999). The presence of VanA VRE was examined in the feces of a total of 1,699 inpatients obtained by the microbiology division of the clinical microbiology of the university hospital of Fujita Health University School of Medicine, Aichi, Japan, between 1 August 1999 and 31 March 2001.
All strains were isolated from feces of patients. E. faecium FH3 and E. avium FH11, and E. faecium FH5 and E. avium FH12, were isolated from patient C and patient E, respectively. Each of the other strains was isolated from a different patient.
Abbreviations: Apc, ampicillin resistance; Gen, gentamicin resistance; Kan, kanamycin resistance; Str, streptomycin resistance; Tet, tetracycline resistance; Tei, teicoplanin resistance; Van, vancomycin resistance. The drug resistance levels of ampicillin, gentamicin, kanamycin, streptomycin, tetracycline, teicoplanin, and vancomycin were equal to or greater than 16, 64, 1,024, 512, 8, 16, and 64 μg/ml, respectively. Enterococcus strains were grown in Todd-Hewitt broth (Difco Laboratories, Detroit, Mich.) throughout this study. Mueller-Hinton broth and Mueller-Hinton agar for the sensitivity disk agar-N (Nissui, Tokyo, Japan) assay were used to test the MICs of antimicrobials. The MICs of the antimicrobials were determined according to the criteria of the National Committee for Clinical Laboratory Standards using Mueller-Hinton agar (32).